These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7486627)

  • 1. A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke.
    Muir KW; Lees KR
    Ann N Y Acad Sci; 1995 Sep; 765():315-6. PubMed ID: 7486627
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke.
    Muir KW; Lees KR
    Stroke; 1995 Jul; 26(7):1183-8. PubMed ID: 7541572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury.
    Natale JE; Guerguerian AM; Joseph JG; McCarter R; Shao C; Slomine B; Christensen J; Johnston MV; Shaffner DH
    Pediatr Crit Care Med; 2007 Jan; 8(1):1-9. PubMed ID: 17251875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled ascending dose tolerance study of 619C89 in acute stroke.
    Muir KW; Lees KR; Hamilton SJ; George CF; Hobbiger SF; Lunnon MW
    Ann N Y Acad Sci; 1995 Sep; 765():328-9. PubMed ID: 7486634
    [No Abstract]   [Full Text] [Related]  

  • 5. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.
    Muir KW; Lees KR; Ford I; Davis S;
    Lancet; 2004 Feb; 363(9407):439-45. PubMed ID: 14962524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose optimization of intravenous magnesium sulfate after acute stroke.
    Muir KW; Lees KR
    Stroke; 1998 May; 29(5):918-23. PubMed ID: 9596235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial.
    Kidwell CS; Lees KR; Muir KW; Chen C; Davis SM; De Silva DA; Weir CJ; Starkman S; Alger JR; Saver JL;
    Stroke; 2009 May; 40(5):1704-9. PubMed ID: 19299636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tolerability, pharmacokinetics and pharmacodynamics of increasing intravenous doses of 619C89, a novel compound for the acute treatment of stroke, in healthy volunteers.
    Mercer AJ; Lamb RJ; Hussein Z; Hobbiger S; Posner J
    Ann N Y Acad Sci; 1995 Sep; 765():324-6. PubMed ID: 7486632
    [No Abstract]   [Full Text] [Related]  

  • 9. Prehospital use of magnesium sulfate as neuroprotection in acute stroke.
    Saver JL; Starkman S; Eckstein M; Stratton SJ; Pratt FD; Hamilton S; Conwit R; Liebeskind DS; Sung G; Kramer I; Moreau G; Goldweber R; Sanossian N;
    N Engl J Med; 2015 Feb; 372(6):528-36. PubMed ID: 25651247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial.
    Saver JL; Kidwell C; Eckstein M; Starkman S;
    Stroke; 2004 May; 35(5):e106-8. PubMed ID: 15017009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study.
    Belfort MA; Moise KJ
    Am J Obstet Gynecol; 1992 Sep; 167(3):661-6. PubMed ID: 1530019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial.
    Temkin NR; Anderson GD; Winn HR; Ellenbogen RG; Britz GW; Schuster J; Lucas T; Newell DW; Mansfield PN; Machamer JE; Barber J; Dikmen SS
    Lancet Neurol; 2007 Jan; 6(1):29-38. PubMed ID: 17166799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous administration of magnesium sulfate in acute stroke: a randomized double-blind study.
    Lampl Y; Gilad R; Geva D; Eshel Y; Sadeh M
    Clin Neuropharmacol; 2001; 24(1):11-5. PubMed ID: 11290876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of magnesium sulfate on characteristics of cerebral hemodynamics under conditions of postischemic brain injury].
    Oleĭnikova ON; Makarova LM; Pogorelyĭ VE
    Eksp Klin Farmakol; 2010 Sep; 73(9):17-9. PubMed ID: 21086647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of serum magnesium sulfate levels in pregnant women with severe preeclampsia between intravenous and intramuscular magnesium sulfate regimens: a randomized controlled trial.
    Manorot M; Tongsong T; Khettglang T
    J Med Assoc Thai; 1996 Feb; 79(2):76-82. PubMed ID: 8868017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium sulfate improves postoperative analgesia in laparoscopic gynecologic surgeries: a double-blind randomized controlled trial.
    Sousa AM; Rosado GM; Neto Jde S; Guimarães GM; Ashmawi HA
    J Clin Anesth; 2016 Nov; 34():379-84. PubMed ID: 27687417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous magnesium sulfate for bronchial hyperreactivity: a randomized, controlled, double-blind study.
    Schenk P; Vonbank K; Schnack B; Haber P; Lehr S; Smetana R
    Clin Pharmacol Ther; 2001 May; 69(5):365-71. PubMed ID: 11372005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paramedic Initiation of Neuroprotective Agent Infusions: Successful Achievement of Target Blood Levels and Attained Level Effect on Clinical Outcomes in the FAST-MAG Pivotal Trial (Field Administration of Stroke Therapy - Magnesium).
    Shkirkova K; Starkman S; Sanossian N; Eckstein M; Stratton S; Pratt F; Conwit R; Hamilton S; Sharma L; Liebeskind D; Restrepo L; Valdes-Sueiras M; Saver JL;
    Stroke; 2017 Jul; 48(7):1901-1907. PubMed ID: 28583999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does neuroprotection improve stroke outcome?
    Lees KR
    Lancet; 1998 May; 351(9114):1447-8. PubMed ID: 9605797
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind, randomized crossover study of intravenous infusion of magnesium sulfate versus 5% dextrose on depressive symptoms in adults with treatment-resistant depression.
    Mehdi SM; Atlas SE; Qadir S; Musselman D; Goldberg S; Woolger JM; Corredor R; Abbas MH; Arosemena L; Caccamo S; Campbell CS; Farooqi A; Gao J; Konefal J; Lages LC; Lantigua L; Lopez J; Padilla V; Rasul A; Ray AM; Simões HG; Tiozzo E; Lewis JE
    Psychiatry Clin Neurosci; 2017 Mar; 71(3):204-211. PubMed ID: 27862658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.